How to Buy Waters Stock
Waters Corp
Waters is a diagnostic & research company located in Massachusetts, United States, which is part of the Healthcare sector, and is traded under the ticker WAT on the NYSE exchange.
Waters stock last closed at $457.60, up 1% from the previous day, and has increased 23.29% in one year. It has underperformed other stocks in the Diagnostics & Research industry by 0.01 percentage points. Waters stock is currently +61.83% from its 52-week low of $282.77, and -5.12% from its 52-week high of $482.28.
At the moment, there are 98.25M WAT shares outstanding. The market capitalization of WAT is $44.96B. In the last 24 hours, 696,000 WAT shares were traded.
How to Buy Waters Stock
Not sure how to invest in Waters stock? Here's how.
- Decide where to buy Waters stock: You need to decide on an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you figure out where to buy Waters stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit funds into your investment account: Choose your payment method and add your info.
- Research Waters stock: The Waters ticker symbol is WAT. Is Waters stock a good investment? Should you buy shares of WAT? How do WAT's underlying business fundamentals look? Do top analysts think Waters is a good buy? Why has WAT's stock price moved recently? (Hint: Our stock market analysis website can help you understand if WAT is a good stock to buy).
- Make your WAT buy order: Decide if you will purchase WAT shares at the current market price or use a limit order to buy WAT shares at a given price.
- Get key alerts regarding your WAT position: Create a watchlist to get the latest news on your investment in Waters stock.
Step 1: Decide where to buy Waters stock
You will need a brokerage account to access the NYSE market and buy WAT stock.
Our preferred brokerage: eToro
In our opinion, eToro is the best place to buy stocks. Here's why:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to world financial markets: From Tech to Utilities, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've picked the right brokerage, you need to fill out some personal details so you can buy WAT today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to open your new trading account.
- Submit your application by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you have created your account on one of the most highly reviewed stock trading apps, you need to deposit funds:
Watch this video walkthrough for more details transferring money into your brokerage account.
Step 4: Research Waters stock
Once you have identified the best place to buy Waters stock, it's very important to analyze their stock before you invest, so you truly understand the risk and upside.
Waters Numbers
Fundamentals of Waters
WallStreetZen was built to help everyday investors perform more in-depth fundamental analysis in less time.
You can view all of the due diligence checks on WAT's stock page.
Is WAT stock overvalued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge WAT's true value.
Using relative valuations measures:
- WAT could be overvalued based on its P/E ratio of 113.55x, relative to Diagnostics & Research industry P/E ratio of 25.21x
- WAT could be undervalued based on its P/B ratio of 2.96x, relative to Diagnostics & Research industry P/B ratio of 4.74x
- WAT could be overvalued based on its PEG ratio of 1.7x
You can do more valuation analysis on WAT's stock here.
Is WAT a healthy company?
Passed Financial Due Diligence Checks:
- Total WAT debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than short-term liabilities on the WAT balance sheet.
Failed Financial Due Diligence Checks:
- WAT earnings of $354.22M is not enough to cover its interest payments.
- WAT profit margin has gone down from 21.7% to 3.6% in the past year.
- There are more long-term liabilities than short-term assets on the WAT balance sheet.
- WAT has a relatively high debt to equity ratio of 0.63.
- WAT's operating cash flow of $549.86M allows it to safely service it's debt of $5.45B.
Do analysts think it's a good time to buy WAT stock
Out of 19 Wall Street analysts who monitor WAT, the consensus analyst rating on WAT is a Strong Buy
It's important to note that analyst forecasts are not recommendations, nor are they financial advice.
Most Recent WAT Analyst Forecasts
Paul Knight, a top 23% analyst from KeyBanc maintains WAT with a strong buy rating and raises their WAT price target from $460.00 to $500.00, on Nov 4, 2026.
KeyBanc's Paul Knight raised their price target on Waters (NYSE: WAT) by 8.7% from $460 to $500 on 2026/11/04. The analyst maintained their Strong Buy rating on the stock.
Waters Corporation reported its Q3 2026 earnings.
Knight highlighted that:
- The quarter beat consensus on both revenue and earnings.
- Management raised its guidance to constant-currency revenue growth of 10% and an adjusted operating margin of 30.1%.
Earnings Report
For Q3 2026, Waters Corporation reported:
- EPS of $4.10, which beat the Zacks Consensus Estimate of $3.99 and, by 21%, Q3 2025’s $3.40.
- Revenue of $1.77B, which beat the Zacks Consensus Estimate by 0.81% and, by 9%, Q3 2025’s $799.89M.
Management guided:
For Q4 2026:
- EPS of $4.58 to $4.68.
- Revenue of $1.801B to $1.819B.
For FY 2026:
- EPS of $14.60 to $14.70.
- Revenue of $6.479B to $6.497B.
President & CEO Dr. Udit Batra commented: "Our team delivered exceptional results led by best-in-class consumables growth across both our Analytical Sciences and Biosciences divisions, as strong execution, new product innovation, and rising customer testing volume accelerated growth.
"LC-MS instrument growth also strengthened, growing double-digit in constant currency, driven by robust instrument replacement trends, idiosyncratic growth drivers across GLP-1s, PFAS, and India generics, and we continued to outperform the market with our leading solutions for complex biologics.
"Thanks to the hard work of our teams, we are delivering ahead of schedule on our synergy and integration commitments for our acquired businesses.
“With improving end market conditions and momentum accelerating across the combined company, we are raising our FY 2026 revenue guidance by $43M at the midpoint, and our Q4 guidance calls for double-digit growth in both our organic and acquired businesses on a days-adjusted basis."
Subbu Nambi, a top 1% analyst from Guggenheim maintains WAT with a strong buy rating and raises their WAT price target from $440.00 to $490.00, on Oct 1, 2026.
Evie Koslosky, a bottom 47% analyst from Goldman Sachs maintains WAT with a strong buy rating and raises their WAT price target from $465.00 to $515.00, on Sep 21, 2026.
Doug Schenkel, a top 11% analyst from UBS upgrades WAT to a strong buy rating and raises their WAT price target from $375.00 to $490.00, on Sep 9, 2026.
David Westenberg, a top 1% analyst from Piper Sandler upgrades WAT to a strong buy rating and raises their WAT price target from $400.00 to $480.00, on Aug 27, 2026.
You can dive deeper into what analysts are forecasting on the Waters stock forecast page.
WAT Technicals
Is WAT Growing Revenue?
Last year, WAT earnings were $166.14M. Over the past 5 year, WAT's earnings have increased by -17.66% per year. This was slower than the Diagnostics & Research industry average of -0.98%.
Last year, WAT revenue was $4.64B. Over the past five year, WAT's revenue has gone up by 11.7% per year. This was faster than the Diagnostics & Research industry average of 6.52%.
Dive into WAT's earnings and revenue performance here.
Are WAT insiders buying or selling the stock?
In the past year, insiders at WAT have sold more shares than they have bought.
Christopher A. Kuebler, Director of WAT, was the latest WAT insider to buy. They bought $494,695.18 worth of WAT stock on Aug 6, 2026.
Dig into more about who owns WAT stock here.
Does WAT provide a stable income stream?
No, Waters doesn't provide an income stream by paying out dividends.
What do other traders have to say about WAT?
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Make your WAT buy order
There are two primary order types:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are usually fine. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a specific dollar amount limit, use a limit order.
Hit the Open button and your broker will execute the order.
If you want more info about buying stocks on eToro, watch the helpful video below:
Step 6: Get key alerts regarding your WAT position
Now that you own some shares in WAT, you'll want to keep up with your investment.
Create a watchlist to get the latest updates about your WAT stock.
WAT Feed
How to Buy Stock in Waters
To summarize, here are the 6 steps for buying Waters stock:
- Decide where to buy Waters stock
- Create your brokerage account
- Deposit funds into your investment account
- Research Waters stock
- Make your WAT buy order
- Get key alerts regarding your WAT position
If you are looking for a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get the latest scoop on your investment in Waters, create a watchlist on WallStreetZen today.
Related Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.